Scientific publications

Frontiers in Immunology, 2026
Integrative analysis of DNA methylation and inflammatory protein biomarkers in hypertension

Zhu M., Zhang J., Ma J. et al.

Frontiers in Medicine, 2026
Extended treatment of abrocitinib: evaluation of efficacy and safety in chronic actinic dermatitis

Tang L., Zhong L., Liang L. et al.

The Journal of Clinical Endocrinology & Metabolism, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease

Gobeil ?., Bourgault J., Gagnon E. et al.

Cancer Science, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

Mouri A., Kagamu H., Tamada K. et al.

Investigative Ophthalmology & Visual Science, 2026
Large-Scaled Proteomics Analysis for Glaucoma: Integrated Genetics, Multi-Omics, UK Biobank and Therapeutic Analysis

Xu J., Gao Y., Yu J. et al.

Mediators of Inflammation, 2026
Convergent Multistage Evidence Implicates the CCR2–Artemin Immune–Inflammation Axis in Acute Myeloid Leukemia

Jin Y., Lu H., Yu X. et al.

Mediators of Inflammation, 2026
Identification of Treatment Targets in Allergic Conjunctivitis Through Proteome‐Scale Mendelian Randomization Analysis

Li H., Zhang Y., Shang Y. et al.

Journal of Neurosurgery: Pediatrics, 2026
Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformations

Hattar Y., Sesen J., Martinez T. et al.

International Journal of Biological Macromolecules, 2026
A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort

Wang H., Li X., Xu X. et al.

Journal of Translational Medicine, 2026
Machine learning-based clinical prediction model and multi-omics integration for assessing pancreatic cancer risk in new-onset diabetes

Yang J., Cao B., Yuemaierabola A. et al.

Journal for ImmunoTherapy of Cancer, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

O’Reilly E., Cabanski C., Lyman J. et al.

Diabetologia, 2026
Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia

Mustafajev I., Hendriksz M., Stienstra R. et al.

Reviews in Cardiovascular Medicine, 2026
Olink Proteomics in Heart Failure: A Comprehensive Review of Applications From Biomarker Discovery to Pathophysiological Insights and Clinical Implementation

Zheng Z., Gong Z., Gu J.

GeroScience, 2026
Liver-specific phenotypic aging, behavior and genetic risks, and long-term liver-related outcomes

Wu T., Guo C., Yuan H. et al.

Nature Medicine, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

Duttagupta S., Messaoudene M., Hunter S. et al.

Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2026
Apolipoprotein E4 and its later-life health effects on the multiple sclerosis population

Zeldich D., Cheng C., Guan Y. et al.

International Journal of Molecular Sciences, 2026
Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns

Parke ?., Strunz B., Chen P. et al.

Biomedicine & Pharmacotherapy, 2026
Differential effects of the anti-obesity drug tirzepatide on adipose tissues: Brown fat as a key target

Mestres-Arenas A., Quesada-López T., Blasco-Roset A. et al.

Journal of Extracellular Vesicles, 2026
Profiling of Extracellular Vesicles of Non‐Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance

Cáceres‐Verschae A., Hååg P., Joelsson S. et al.

Medicina, 2026
Explorative Insights into Local Immune Response to BK Virus—A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts

Michnowska A., Wojciuk B., Reus P. et al.